Part One · 1908–2011

A Century of Endometriosis

From Cullen’s 1908 monograph to a proposal that adenomyosis and endometriosis were one disease all along — this visualization shows the sequence of events described in Brosens and Benagiano’s review covering the time period 1908–2011. Interact with the timeline and explore categories and terms below, or use the search in the top navigation to find a specific entry.

Interactive Timeline

Each mark on the timeline represents an event. Scrub across the timeline to preview events, then tap Go to Event to view the full details.

Interactive Timeline

Each mark is one dated event — hover to preview it, click to jump to it below.

Identifying the disease1908–19325
1908Cullen’s monograph names one disease

Thomas Cullen’s Adenomyoma of the Uterus. The authors set three tests before credit can be given: finding epithelial structures outside the uterine cavity, identifying them as endometrial glands and stroma, and understanding that the invasion was benign rather than neoplastic. Cullen met all three, which is the basis for their argument against crediting Carl Rokitansky.

“We have argued against this attribution as, in our view, there are three conditions that must be met before credit can be given for having identified the two pathologies: (i) to have found the presence of epithelial structures outside the uterine cavity; (ii) to have identified these as endometrial glands and stroma; and (iii) to have clearly understood that this invasion was ‘benign’ (and therefore, ‘non neoplastic’) in nature. Using these criteria, there is no doubt that it was the surgeon Thomas Cullen who described for the first time the full morphological and clinical picture of endometriosis and adenomyosis.”

1920Cullen maps the classic pelvic sites

His scheme placed ectopic endometrial-like tissue in the myometrial wall, rectovaginal septum, hilus of the ovary, uterine ligaments, rectal wall, and umbilicus. He treated uterine adenomyoma, ovarian endometriosis, and deep endometriosis as a single condition — a view the paper says is gaining evidence again.

“In 1920, he drew a scheme with the classic sites of adenomyotic lesions in the pelvis. He correctly mentioned that the condition, called in these days adenomyoma, involved the presence of ectopic endometrial-like tissue in the myometrial wall, rectovaginal septum, hilus of the ovary, uterine ligaments, rectal wall and umbilicus. Cullen considered uterine adenomyoma, ovarian endometriosis and deep endometriosis as one disease characterized by the presence of adeno-myomatous tissue outside the uterine cavity and today there is increasing evidence that he may have been right.”

1921Sampson on ovarian chocolate cysts

His paper on perforating hemorrhagic cysts of the ovary appeared seven years before he gave the disease its name.

“It was John A. Sampson who created the name endometriosis seven years after his fundamental paper on ovarian endometriomas.”

1927Sampson names endometriosis

Operating on women during menstruation, he found the peritoneal lesions bleeding much as eutopic endometrium does — proof to him that the tissue outside the uterus was endometrial in origin. He postulated tubal regurgitation and dissemination of menstrual shedding. The theory would keep endometriosis separated from adenomyosis for the next several decades.

“His original observation came when he operated women at the time of menstruation and found that the peritoneal lesions were bleeding, similarly to what happens in eutopic endometrium, proving to him that the tissue outside the uterus was of endometrial origin. In 1927, Sampson postulated that presence of endometrial cells outside the uterus was due to tubal regurgitation and dissemination of menstrual shedding.”

1932Hill reports 135 surgical cases

Twenty had uterine adenomyomas and 115 had peritoneal endometriosis. Most patients were between 20 and 45, the youngest 16 and the oldest 61. Menstrual pain was the main reason for seeking surgery, typically about ten years after onset, and Hill noted that symptoms were progressive.

“In 1932, Hill Jr. reported the presence of aberrant endometrium at microscopy in a series of 135 patients who were operated-upon for some pelvic pathology. Amongst these cases, 20 had adenomyomas of the uterus and 115 had peritoneal endometriosis. The majority of the patients were between 20 and 45 yr of age, with the youngest being 16 yr old and the oldest 61. Pelvic pain related to menstruation was the principal reason for seeking relief through surgery and this usually happened some ten-years after the onset of disease; in addition he mentioned that symptoms were progressive.”

Early hormonal and surgical attempts1941–196011
1941Geist and Salmon advocate androgens

Their paper on androgen therapy in gynecology opened the first hormonal line of attack. Androgens, not estrogens, came first.

“The first suggestion came from Geist and Salmon who, in 1941 advocated the use of androgens in gynaecological disorders.”

1944Miller uses testosterone propionate

He reported that it diminished lesion activity and reduced lesion size, so that radical surgery could be performed with less danger. Hirsutism, acne, and deepening of the voice occurred often enough to concern both clinicians and patients, and androgen therapy never really took off.

“In 1944, Miller wrote: ‘testosterone propionate can be used in diminishing the activity and decreasing the size of the lesions in endometriosis so that radical surgery can be performed with less danger.’ In spite of the positive results obtained, the undesirable side effects of hirsutism, acne, and deepening of the voice occurred sufficiently often to cause the clinician and the patient considerable concern. For this reason, androgen therapy never really took off.”

1945Karnaky treats with diethylstilbestrol

Escalating doses of up to 100 mg a day produced amenorrhea. He concluded that large continuous doses did not stimulate the disease though small ones might. Five patients conceived after the drug was stopped — pregnancies the authors note should, with hindsight, have been followed closely.Date discrepancy: the body of the review says 1945, but the cited paper in the Southern Medical Journal is dated 1948.

“The first to do so was Karnaky who, in 1945, reported apparently good results, achieving amenorrhoea with increasing daily doses of up 100 mg/day of diethylstilbestrol (DES). In his report he reached at an intriguing conclusion: ‘endometriosis is not stimulated to grow by large continuous doses of stilbestrol, but small doses of stilbestrol may stimulate it.’ In his series, five patients became pregnant after stilbestrol was discontinued.”

1948Novak and de Lima re-link the two conditions

Of 134 women with adenomyosis, 42 — just over 31% — also had endometriosis. They wrote that they could not resist the feeling that some common denominator connected endometrial hyperplasia, adenomyosis, and possibly pelvic endometriosis too.

“In 1948 Novak and de Lima linked them again hypothesising a specific local hormonal reaction in ectopic endometrium. They wrote: ‘one cannot resist the feeling that there is some common denominator between endometrial hyperplasia and adenomyosis, and possibly also pelvic endometriosis.’ Their statement was based on the observation that, of a total of 134 women with adenomyosis, endometriosis was also present in 42 (31.3%).”

late 1940sCuldoscopy opens the pelvis to view

The new endoscopic route was claimed to be invaluable for pelvic tumours, small ovarian disease, endometriosis, and ectopic pregnancy, and especially helpful in studying primary and secondary infertility.

“New pelvic endoscopic techniques were introduced in gynaecology in the late 1940s. Culdoscopy was a new procedure for pelvic visualization in gynaecology and it was claimed that the procedure was invaluable in the investigation of pelvic tumours, small ovarian disease, endometriosis, ectopic pregnancy and especially helpful in the detailed study of primary and secondary sterility in females.”

1953Meigs urges early marriage and childbearing

He held that avoiding endometriosis through early marriage and frequent childbearing was the most important method of prophylaxis, and even exhorted patients to subsidize their sons and daughters to make it financially feasible. His target was painful rectovaginal adenomyoma and ovarian endometrioma in young women, for whom hysterectomy and castration were then the only surgical cure.

“In 1953, Meigs recommended early and frequent childbearing as prophylaxis and even exhorted patients to subsidise their sons and daughters so that this approach may become financially feasible. He wrote: ‘It is the author’s belief that avoidance of endometriosis through early marriage and frequent childbearing is the most important method of prophylaxis.’ Obviously, Meigs was not referring to peritoneal endometriosis; rather he was attempting to solve the challenges of those days: painful rectovaginal adenomyomas and cystic ovarian endometriomas in young women for whom at that time hysterectomy and castration were the only surgical cure.”

1956Rock, Pincus, and Garcia test 19-nor steroids

Their work on the effects of these compounds on the human menstrual cycle, in the quest for a hormonal contraceptive, ran strikingly parallel to Kistner’s reasoning about why pregnancy seemed to help.

“This concept bears striking similarity to the approach taken by Rock et al approximately the same time in their quest for a hormonal contraceptive.” (Reference 27: Garcia CR, Pincus G, Rock J. “Effects of certain 19-nor steroids on the human menstrual cycle.” Science. 1956;124:891–3.)

1957Hughesdon reframes the endometrioma

In 29 ovary specimens with chocolate cysts, 90% proved to be pseudocysts. The ovarian surface adheres, usually to the posterior parametrium, part of the cortex invaginates, and a thin layer of endometrium-like tissue covers it. The ovary is actively invaginated rather than simply eroded — a pseudocyst mimicking a uterus.

“In a detailed study of 29 ovary specimens with chocolate cysts, Hughesdon found that in 90 per cent of them the ovarian endometrioma was formed by a pseudocyst. The surface of the ovary is adherent, usually to the posterior side of the parametrium and part of the ovarian cortex is invaginated... Hughesdon concluded that ectopic endometrium does not simply erode its way into the ovary: the ovary is actively invaginated, thus, providing a pseudocyst mimicking a uterus.”

1958Kistner proposes pseudopregnancy

Reasoning that decidualization explained pregnancy’s benefit, he gave 12 patients large doses of estrogens and progestins on a graduated scale for up to seven months, producing amenorrhea and a decidual reaction. He also observed that androgens probably worked by inhibiting gonadotropins — an intuition that sent others looking for gonadotropin inhibitors — and judged estrogen-only therapy unwise given breakthrough bleeding and hyperplasia.

“The idea led Kistner to propose, in 1958, a more practical alternative: induce a state of ‘pseudopregnancy’ to reproduce the improvement noted in endometriosis during and after pregnancy. He postulated that the positive effect of pregnancy was due to decidualization that results in necrosis and elimination of superficial endometriotic implants... His first experimental treatments involved 12 patients to whom large doses of a number of oestrogenic compounds and two progestins were administered in a ‘graduate scale’ for periods of time up to 7 months to produce amenorrhoea, as well as a decidual reaction in the endometrium.” Elsewhere: “In 1958, commenting on the use of androgens Kistner noted that ‘androgenic substances... probably exert their effect through inhibition of gonadotropic substances.’” And: “In 1958 Kistner wrote: ‘the unpredictability of permanent relief in endometriosis following the use of oestrogenic substances alone’ and the fact that ‘oestrogen therapy also has the disadvantage of occasionally resulting in rather profuse break-through bleeding, endometrial hyperplasia and hypermenorrhea...’ make this treatment unwise.”

1959Andrews reports on the same regimen

His clinical and microscopic studies of progestin-induced pseudopregnancy give him shared credit with Kistner for the approach.

“Two researchers Kistner and Andrews share the credit for the advent of ‘pseudo-pregnancy’ as a treatment for endometriosis.” (Reference 41: Andrews MC, Andrews WC, Strauss AF. “Effects of progestin-induced pseudopregnancy on endometriosis: clinical and microscopic studies.” 1959.)

1960Enovid tried in 23 women

The first oral contraceptive ever marketed produced decidual transformation in eutopic endometrium consistently, and in ectopic endometrium in all five cases where tissue was available. Fourteen of the 17 patients treated for pain improved during therapy.

“The first oral contraceptive ever marketed, Enovid (norethinodrel plus mestranol) was administered to 23 women with endometriosis. Decidual transformation was consistently demonstrated in the eutopic endometrium and was present in the ectopic endometrium in all of the five instances in which it was obtained for study. Clinical improvement during therapy was observed in 14 of the 17 patients treated because of pain.”

The laparoscopy era1960s–19796
1960sLong-acting steroids extend the regimen

Amenorrhea persisted throughout hormone administration and most patients had considerable to complete relief. Estrogen-progestin therapy was used widely from this point on, with reported pregnancy rates in women who were also infertile ranging from 10 to 53% — though the combinations were never properly tested.

“To improve the effectiveness of the pseudo-pregnancy regimen, long-acting steroid hormones were introduced in the 1960s. Patients developed amenorrhoea, which persisted throughout the period of hormone administration, and most of them experienced considerable to complete relief of their symptoms... pregnancy rates in women who complained of infertility in addition to endometriosis ranged from 10 to 53 per cent. It is unfortunate that, although extensively utilized, oestrogen-progestin combinations have not been properly tested. Indeed, a 2007 Cochrane systematic review... found only one study that met the inclusion criteria.”

1967Semm builds modern laparoscopy

He improved the optical system, moved the light source out of the abdominal cavity and created automatic control of gas insufflation, turning what was then called peritoneoscopy into a practical surgical tool.

“Starting in 1967, Semm, transformed what was called at the time ‘peritoneoscopy’ into modern laparoscopy by improving the optical system, removing the source of light from the abdominal cavity and creating an automatic control of gas insufflations into the abdomen.”

1971Greenblatt introduces danazol

The first antigonadotropic steroid for endometriosis. The authors note it turned the clock back: danazol has definite androgenic properties and could produce symptoms not very different from those reported in the 1940s.

“The first being an antigonadotropic steroid, danazol. Its introduction in 1971 by Greenblatt et al brought back the clock, since this compound has definite androgenic properties and may produce symptoms not very different from those reported in the forties.”

early 1970sLaparoscopy becomes the standard

Endoscopic methods for hemostasis, ligature, and suture arrived, and leading gynecologists in Europe and the United States concluded that laparoscopy was the preferred tool for both diagnosis and surgery. Peritoneal endometriosis became the signature form of the disease, and research turned to how menstrual fragments implant.

“In the early 1970s leading gynaecologists in Europe and US concluded that laparoscopy is the preferred tool for diagnosis and surgery of endometriosis... especially when, in the early 1970s, endoscopic methods for haemostasis, ligature and suture during surgical pelviscopy were introduced.” Elsewhere: “Clearly, peritoneal endometriosis became the signature of endometriosis... and research became focused on how fragments of menstrual endometrium implant on peritoneal surfaces and invade the underlying tissues.”

1975Kistner on conservative surgery

Roughly 40 to 50% of women wanting children may conceive, usually within 24 months, though for a few the delay may stretch to three or four years. He named five factors governing the outcome: extent of disease, age, prior surgery for endometriosis, duration of infertility beforehand, and length of follow-up.

“In 1975 Kistner noted that approximately 40 to 50 per cent of patients who are desirous of childbearing and who have had conservative surgical treatment will become pregnant. Such pregnancy usually occurs within the first 24 months, although in a few patients, the delay may be of 3 or even 4 years. Kistner observed that pregnancy rates were influenced by 5 factors: the extent of disease; the age; the history of additional prior surgery for endometriosis; the duration of infertility before surgery; and the length of post-surgical follow up.”

1979Buttram reports pregnancy rates by stage of disease

Seventy-three, 56 and 40% for mild, moderate and severe disease respectively. Because surgery helped most in the early post-operative period, he argued that suppressive medical therapy should be given before the operation rather than after it.

“A few years later, Buttram reported pregnancy rates of 73, 56 and 40 per cent respectively, for patients with mild, moderate and severe endometriosis. As surgery was most beneficial in the early post-operative period he recommended that, if medical suppressive therapy is to be used in conjunction with conservative surgery to enhance fertility, it should be instituted preoperatively rather than postoperatively.”

Peritoneal environment and controlled trials1981–1990s9
1981Immunity and inflammation implicated

Dmowski’s group was first to propose a role for the immune system, showing that rhesus monkeys with spontaneous endometriosis had an altered cellular response to autologous antigens — suggesting displaced endometrial cells implant only where cell-mediated immunity is altered. Haney separately showed a chronic intraperitoneal inflammatory process, with more peritoneal macrophages in infertile women with endometriosis than in controls.

“Dmowski and collaborators were the first to advocate, in 1981, a role of the immune system in the pathogenesis of endometriosis. This Group demonstrated that rhesus monkeys with spontaneous endometriosis have an altered cellular immune response to autologous antigens... Haney et al in 1981 demonstrated that endometriosis is accompanied by a chronic intraperitoneal inflammatory process, as shown by the increased number of peritoneal macrophages in infertile women with endometriosis compared with normal women or women with other causes of infertility.”

1983Halme finds activated macrophages

Increased activation of pelvic macrophages in infertile women with mild disease. Routine laparoscopy for sterilization and infertility work-ups had made peritoneal fluid easy to collect, and an avalanche of pathogenesis research followed.

“A first major finding was an increased activation of peritoneal macrophages in infertile women with mild endometriosis.” Elsewhere: “This was made possible thanks to the increasing use of laparoscopy for tubal sterilisation, or the exploration of infertility: peritoneal fluid could easily be collected for research purposes and carefully analysed. This resulted in an avalanche of publications on the pathogenesis of endometriosis.”

1984Retrograde menstruation is near-universal

Halme showed that reflux through the fallopian tubes is a common physiologic event in most menstruating women with patent tubes. If nearly everyone refluxes, additional factors must determine who develops the disease.

“Halme et al demonstrated that retrograde menstruation through the fallopian tubes into the peritoneal cavity is a very common physiologic event in most menstruating women with patent tubes and, therefore, additional factors must be implicated in the genesis of endometriosis.”

1986Jansen links minimal disease to fertility

A prospective study within an artificial insemination by donor program found reduced fecundability even with minimal endometriosis — raising the stakes on the subtle lesions being newly recognized, though their clinical significance stayed controversial.

“The clinical importance of even very small lesions was suggested when, in a prospective study of artificial insemination in women with minimal endometriosis, Jansen found reduced fecundability. Awareness of the existence of subtle peritoneal endometriosis produced an increase in the diagnosis of endometriosis, although clinical significance of early lesions remained controversial.”

1986Nezhat applies carbon dioxide laser

Used to remove implants, excise endometrioma capsules and lyse adnexal adhesions. In a series of 102 patients he reported a 60% pregnancy rate within 24 months without additional hormonal therapy, and laparoscopic vaporization became a popular option despite thin evidence.

“Nezhat et al introduced carbon dioxide laser for the removal of endometriotic implants, excision of endometrioma capsules, and lysis of adnexal adhesions. In a series of 102 patients, they reported a pregnancy rate of 60 per cent within 24 months after laser surgery without additional hormonal therapy. Laparoscopic vaporisation with carbon dioxide laser became a popular treatment modality for endometriosis-associated infertility, yet little data existed regarding the effectiveness of such an approach.”

1989Gestrinone compared with danazol

Fedele found both reduced dysmenorrhea, pelvic pain, and deep dyspareunia, with no significant difference between them. Venturini showed gestrinone lowered total testosterone and sex hormone binding globulin while free testosterone rose slightly.

“Fedele and co-workers were the first to compare the clinical effects of gestrinone and danazol, observing a significant decrease of pain-related symptoms (dysmenorrhoea, pelvic pain, deep dyspareunia) in both groups, without any significant difference. The same year Venturini and co-workers showed that gestrinone significantly reduces serum concentrations of total testosterone and sex hormone binding globulin (SHBG), whereas free testosterone is slightly, but significantly, increased.”

1994A meta-analysis and the first laser trial

Adamson and Pasta concluded that either no treatment or surgery outperformed medical therapy for minimal and mild disease associated with infertility, and that laparoscopy and laparotomy gave comparable results in advanced disease. Sutton’s prospective double-blind trial found laser laparoscopy safe, simple, and effective for pain in stage I to III.

“In 1994 Adamson and Pasta carried out a meta-analysis and concluded that either no treatment or surgery is superior to medical treatment for minimal and mild endometriosis associated with infertility; in addition, in moderate and severe disease, surgery seems to yield comparable results with both operative laparoscopy or laparotomy... One such study was published in 1994 by Sutton et al who concluded that laser laparoscopy was a safe, simple and effective treatment in alleviating pain in women with stage I, II and III endometriosis.”

1997A second trial, and a synthesis

Marcoux showed laparoscopic surgery enhanced fecundity in infertile women with minimal or mild disease. Ryan and Taylor drew the era together around three concepts: a local peritoneal inflammatory process, angiogenic factors enabling ectopic implants, and biochemical differences between the eutopic and ectopic endometrium of affected women.

“In 1997, Marcoux et al published a second randomised, controlled trial and concluded that laparoscopic surgery enhanced fecundity in infertile women with minimal and mild endometriosis.” Elsewhere: “In a review published in 1997, Ryan and Taylor concluded that three general concepts steered during the late 20th century research in endometriosis. First, there is evidence of a local peritoneal inflammatory process... Second, there is a role for angiogenic factors in the establishment of ectopic implants. Third, there is evidence for biochemical differences of eutopic and ectopic endometrium in endometriosis patients.”

late 1990sRectal endoscopic ultrasound

Proposed for detecting deep bowel infiltration and selecting patients for surgery, alongside transrectal ultrasound for rectovaginal disease. Pain correlated poorly with stage but strongly with depth — implants deeper than 10 mm were the ones that hurt.

“In the late 1990s rectal endoscopic ultrasonography was proposed to diagnose the presence of deep bowel infiltration and select patients for surgery.” Elsewhere: “A strong correlation between pelvic pain and the depth of invasion was described in the presence of implants more than 10 mm deep.”

Toward a unified syndrome2005–20114
2005Levonorgestrel IUS matches a GnRH agonist

A randomized controlled trial found the LNG-IUS and a depot GnRH analogue comparably effective for chronic pelvic pain in severe endometriosis. The device avoids hypoestrogenism and needs one intervention every five years, making it a candidate first choice for women not seeking pregnancy.

“A recent prospective, randomised, controlled clinical trial compared the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena) with a depot formulation of a GnRHa in the control of endometriosis-related chronic pelvic pain (CPP) in patients with severe endometriosis. Both treatment modalities showed comparable effectiveness... Among the additional advantages of the LNG-IUS is the fact that it does not provoke hypoestrogenism and requires only one medical intervention (for its introduction) every 5 years. This device could, therefore, become the treatment of choice for CPP-associated endometriosis in women who do not wish to conceive.”

2007Cochrane finds almost no evidence

A systematic review of combined oral contraceptives for endometriosis-related pain found only one study meeting the inclusion criteria — after decades of routine prescribing. The authors use this to argue for prospective randomized trials of a pseudopregnancy regimen in adolescents.

“A 2007 Cochrane systematic review aimed at assessing the effects on pain-related symptoms of oral contraceptives when compared to other treatments, found only one study that met the inclusion criteria.” Elsewhere: “Because the Cochrane review concluded that there remains a paucity of information regarding the long-term benefits of COCs in the treatment of endometriosis, prospective randomised studies using a pseudo-pregnancy scheme should be performed in adolescents with the presumptive clinical diagnosis of early endometriosis.”

2009Trauma and preconditioning theories

Leyendecker proposed that chronic uterine peristalsis or phases of hyperperistalsis cause micro-trauma at the endometrial-myometrial interface, activating tissue injury and repair with local estrogen production — and in time, permanent hyperperistalsis that perpetuates itself. Separately, Brosens proposed that menstruation preconditions the uterus for pregnancy, with endometriosis as a disease of exaggerated preconditioning that also lets endometrial cells survive in hostile ectopic sites.

“Leyendecker et al proposed a new unified concept... found circumstantial evidence suggesting that endometriosis and adenomyosis are caused by trauma. In other words, chronic uterine peristaltic activity or phases of hyper-peristalsis induce, at the endometrial-myometrial interface, micro traumas with the activation of the mechanism of ‘tissue injury and repair’, followed by the local production of oestrogen; in due course, this results in permanent hyper-peristalsis and a self-perpetuation of the disease process.” Elsewhere: “It is tempting to speculate that endometriosis is primarily a disease of exaggerated endometrial preconditioning, which not only confers protection against hyper-inflammation and oxidative stress associated with pregnancy, but also endows endometrial cells with the mechanisms to survive in unfavourable ectopic locations.”

2011This review proposes EIMDS

The Endometrium and Inner Myometrium Dysfunction Syndrome frames adenomyosis and endometriosis as two phenotypes of one disorder, rather than diseases of the junctional zone alone. Its consequences run well beyond displaced tissue, taking in infertility, miscarriage, preterm rupture of membranes, preterm birth, growth restriction, and pre-eclampsia. The authors close by arguing for early, symptom-oriented treatment in adolescence over lesion-oriented surgery.

“Today we are proposing a new theory, namely that adenomyosis and endometriosis are phenotypes of the same disorder: the ‘Endometrium and Inner Myometrium Dysfunction Syndrome’ (EIMDS)... the dysfunction results in a spectrum of pregnancy disorders involving infertility, miscarriage and major pregnancy complications such as preterm rupture of the membranes, preterm birth, small for gestation age and pre-eclampsia.” Elsewhere: “Rather than surgery, a ‘symptom-oriented’ treatment based on 6-month pseudopregnancy regimen, can be a first line recommendation... In the absence of severe endometriosis a ‘problem-orientated’ rather than ‘lesion-orientated’ treatment may be indicated.”

The history above ends in 2011, but the research didn’t stop there. What follows isn’t a continuation of that timeline — it’s a wider picture, current as of 2021, of a disease now being studied from a dozen directions at once: genetics, biomarkers, treatment, and more. If you’re wondering what’s changed lately, this is where to look.

Part Two · Ongoing Scientific Discovery

Endometriosis, Continuing Exploration of New Technologies

The research doesn’t move in a straight line anymore — it fans out into epidemiology, genetics, biomarkers, and treatment all at once. A topic-by-topic look at where the science stands, drawn from Smolarz, Szyłło, and Romanowicz’s 2021 review. Open a topic, then any finding within it.

Eight topics, drawn from the review’s own structure — its history section is skipped here since Part One already covers that ground. Click on a topic to view in detail below.

EpidemiologyWho it affects5
Prevalence10–15% of reproductive-age women

That rises to 35–50% among women with pelvic pain or infertility. Most cases fall between menarche and menopause, peaking between ages 25 and 45, though the disease also turns up in adolescents and — less often — after menopause.

“This disease affects from 10–15% of women of reproductive age and 35–50% of women with pelvic pain and/or infertility. However, it should be noted that there are also cases of patients with endometriosis after menopause, and it also happens in adolescent women. The vast majority of cases of endometriosis occur in women between menarche and menopause. The peak of the disease falls in the period between 25 and 45 years of age.”

Surgical seriesFound in up to 53% of laparoscopies

Literature reports endometriosis in 0.1–53% of women operated on laparoscopically or by laparotomy — 12–32% of those scoped for pelvic pain, and 10–60% of those scoped for infertility.

“Literature data indicate that endometriosis is found in 0.1–53% of women operated on laparoscopically or by laparotomy, of which 12–32% are women after diagnostic laparoscopy due to pelvic pain delays and 10–60% of the patient after diagnostic laparoscopy due to disability.”

Family & raceA genetic and demographic pattern

About 7% of cases carry a family history. The disease shows up in 2% of women after tubal ligation and 17% after ovarian surgery. Risk is lowest in Black women and highest in Asian women, with Caucasian women at higher risk than Black women.

“Endometriosis in 7% of women is associated with their genetic predisposition in the family. This disease was found in 2% of women undergoing tubal ligation and 17% of women after surgery to remove the ovaries... The risk of developing endometriosis is the lowest in black women, the highest in Asian women. Caucasian women have a higher risk of getting sick than black women.”

Rare presentationsFetuses, and men on hormone therapy

Isolated cases of endometriosis-like foci have been reported in fetuses, and in men undergoing hormone therapy for prostate cancer — evidence for how directly the disease tracks estrogen exposure rather than female anatomy alone.

“World literature also reports the occurrence of foci of endometriosis in fetuses. There have been isolated cases of endometriosis in men around the world who have been treated with hormones for prostate cancer.”

Cost€0.8–12.5 billion a year in Europe

Treatment costs vary by country but land in the same range as other major chronic diseases like diabetes — before accounting for the disease’s toll on relationships, education, and career.

“The annual costs of endometriosis treatment in Europe range from €0.8 billion to €12.5 billion depending on the country and are comparable to other chronic diseases such as diabetes.”

SymptomsWhat it looks like5
Core profilePain that starts young

Dysmenorrhea, pelvic pain, painful ovulation and intercourse, pain on urination or defecation, irregular heavy bleeding, infertility, and chronic fatigue. In 66% of women the first symptoms appear before age 20 — though advanced disease can be silent, and small peritoneal foci can be disproportionately painful.

“In 66% of women with endometriosis, the first symptoms of the disease appear before the age of 20. Symptoms of endometriosis include: gradually increasing acute premenstrual pain, pelvic pain, pain in the sacral region of the spine, dysmenorrhoea, painful ovulation, pain during intercourse, pain when defecating, pain when urinating, pain radiating to the back, abundant irregular menstruation, blood in the stool, diarrhea or constipation, infertility and chronic fatigue... Sometimes very advanced endometriosis may not cause any symptoms, and, paradoxically, small foci within the peritoneum can cause great pain.”

The delay8 to 10 years to diagnosis

That’s the typical gap between first symptoms and confirmed diagnosis — largely unchanged despite better imaging, and a big part of why the disease is described as underdiagnosed rather than rare.

“The time from the appearance of the first symptoms of the disease to the diagnosis is up to 8 to 10 years.”

A separate entityAdenomyosis splits off

Long classified as "endometriosis genitalis interna," adenomyosis — ectopic endometrium within the uterine muscle itself — has recently been shown to differ enough in symptoms, pathogenesis, and treatment to be treated as its own disease. It’s usually diagnosed between ages 40 and 50, more often in women who have given birth, and its cause remains as unclear as endometriosis’s own.

“Due to its significant similarity to endometriosis, adenomyosis has so far been classified as endometriosis genitalis interna, in which endometrial foci are located within the muscle membrane of the uterus. In recent years, the distinctiveness of this disease entity has been proven, indicating differences in symptomatology, pathogenesis and treatment... The average age of diagnosis of adenomyosis is between 40 and 50 years of age... Adenomyosis is more common in multiparous women than in nulliparous women. The cause of adenomyosis is still unknown.”

Deep diseaseDeep infiltrating endometriosis (DIE)

Defined as ectopic tissue infiltrating more than 5mm below the peritoneum, reaching the uterosacral ligaments, rectovaginal septum, bladder or bowel wall. Beyond classic pain, DIE is linked to pelvic floor muscle dysfunction — women with DIE show higher muscle tone and lower strength on transperineal ultrasound than women with ovarian disease alone.

“Deep infiltrating endometriosis (DIE) is defined as the presence of ectopic endometrial tissue infiltration under the peritoneum, pelvic structure, and organ walls, including the uterosacral ligaments, rectosigmoid colon, vagina, rectovaginal septum, bladder, ureter, and lateral parametrium... Women with DIE have a smaller area of the levator hiatal area (LHA), and dynamic maneuvers with three-dimensional (3D) and four-dimensional (4D) transperineal ultrasound suggest they have higher muscle tone and lower strength... than those without DIE.”

A specific subtypeLateral parametrial endometriosis and the bladder

When disease involves the lateral parametrium, it more often comes with ureteral stenosis and voiding dysfunction — straining, incomplete emptying, intermittency — likely through its effect on the pelvic nerve plexus that controls the urethral sphincter.

“The presence of lateral parametrial endometriosis (LPE) can be considered a reflection of a more severe disease, ureteral stenosis and dilatation, and voiding dysfunctions, mainly because of the involvement of the inferior hypogastric plexus. Patients with LPE reported more frequent constipation and voiding symptoms. Associations exist between LPE and straining to void, the feeling of incomplete emptying, intermittency, and abnormal residual urine and bladder outlet obstruction.”

Risk factorsWhat raises the odds4
Reproductive historyEarly menarche, short cycles

A first period before age 11, or cycles shorter than 27 days, are both associated with higher risk — more exposure to menstrual flow over a lifetime being the presumed mechanism. Genital tract defects that favor retrograde flow, such as hymen overgrowth, add to the risk.

“Early menarche—epidemiological studies analyzing the cycle of women with endometriosis have shown that the early first cycle (before the age of 11) is associated with the risk of endometriosis... Shorter than 27-day genital cycles, genital defects, including hymen overgrowth or narrowing of the cervical canal. The risk of endometriosis is increased in women with short cycles, i.e., lasting less than 27 days, but is unrelated to the number of bleeding days and the volume of menstruation.”

Body weightThe BMI picture has reversed

Low BMI was long listed as a risk factor. Newer data complicate that: there’s generally no overall association between BMI and endometriosis, but incidence has risen significantly among obese women specifically, and obesity is its own risk factor for severe dysmenorrhea.

“Endometriosis is more often diagnosed in infertile women who are active smokers and whose body mass index (BMI) is normal or low. Interestingly, the latest data indicate that there is generally no association between BMI and the incidence of endometriosis, but there has been a significant increase in the incidence of endometriosis in obese women compared to women with normal body weight. Obesity is also a risk factor for severe dysmenorrhoea.”

1991–2013Red meat, in a 81,908-woman cohort

Yamamoto and colleagues tracked diet against laparoscopically confirmed endometriosis over more than two decades. Women eating more than two servings of red meat a day had a 56% higher risk than those eating one serving a week or less. Poultry, fish, shellfish, and eggs showed no such link — vegetables and fruit, by contrast, were protective.

“In the latest research by the team of Yamamoto et al., an attempt was made to determine whether higher consumption of red meat, poultry, fish and seafood is associated with the risk of laparoscopically confirmed endometriosis. The study group consisted of 81,908 women, and the observations covered the years from 1991 to 2013... It was shown that respondents who reported eating > 2 servings/day of red meat had a 56% higher risk of endometriosis compared to those consuming ≤ 1 serving/week... No association with poultry, fish, shellfish and egg consumption and the risk of endometriosis was demonstrated.”

DemographicsCaucasian race, age 25–29, daily alcohol

Rounding out the risk profile: Caucasian ethnicity, the 25–29 age band specifically, and daily alcohol intake of at least 10g. Endometriosis is also diagnosed more often in infertile women who smoke and have a normal-to-low BMI.

“Low BMI, Small number of births, Caucasian race, Age 25–29, Daily consumption of alcohol in the amount of at least 10 g per day, Endometriosis is more often diagnosed in infertile women who are active smokers and whose body mass index (BMI) is normal or low.”

PathogenesisCompeting mechanisms4
Still dominantRetrograde menstruation’s unsolved gap

About 80% of women with open fallopian tubes show retrograde menstrual flow, yet only a fraction develop endometriosis. Sampson’s theory explains how tissue gets there — not why it survives and implants in some women and not others.

“The theory of Samson (‘retrograde menstruation’) is more widespread. It says that the foci of endometriosis arise as a result of the displacement of menstrual blood into the peritoneal cavity through the fallopian tubes... Literature data indicate that in 80% of women with open fallopian tubes there is a retrograde outflow of menstrual blood, while endometriosis occurs only in some. This suggests the presence of other factors determining the survival of endometrial cells in the peritoneal cavity and their implantation.”

The immune angleMacrophages, cytokines, and a Th1/Th2 tilt

Women with endometriosis show more activated, less effective macrophages in the peritoneal cavity, elevated pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-8 among them), a shift toward Th2-dominant immune signaling, and reduced natural killer cell activity — collectively a weaker peritoneal "clean-up" of displaced tissue.

“An increased number of activated macrophages with a reduced ability to phagocytose in the peritoneal cavity is characteristic of women with endometriosis. They secrete pro-inflammatory cytokines, such as IL-6, TNF-α, IL-1β and IL-8, in increased amounts... According to literature data, Th2 lymphocytes gain an advantage in women with endometriosis. In women with endometriosis, reduced Natural Killer (NK) cell activity is found.”

An older alternativeCoelomic metaplasia

Meyer’s metaplasia theory holds that cells with mesodermal origin — precursors shared by the ovarian and pelvic peritoneal lining — transform into endometrium-like tissue under hormonal influence. It’s the theory best able to explain endometriosis turning up somewhere the retrograde-flow theory can’t reach, like the pleural cavity.

“Mayer’s theory... says that peritoneal cells are transformed into Muller-type cells under the influence of hormones. This theory is based on the assumption of the existence of cells capable of differentiating in the endometrium and those cells being precursors of the mesodermal epithelium of the ovary and the pelvic peritoneum. This theory is particularly useful in explaining the existence of endometriosis in different regions of the body where there is a mesothelium, e.g., pleural cavity.”

Vascular growthNew vessels, new nerves, more pain

Ectopic endometrium can’t establish itself without new blood vessels, and VEGF-driven angiogenesis in the peritoneal fluid correlates with disease stage. Neo-angiogenesis arrives together with new nerve growth — a plausible link between lesion growth and the pain it causes.

“The formation of new vessels is a necessary condition for the development of the ectopic endometrium, especially in the peritoneal microenvironment. Neo-angiogenesis is accompanied by the formation of nerves, which may explain the pain in patients. Vascular endothelial growth factor (VEGF) is responsible for the formation and growth of new vessels. In women with endometriosis, elevated concentrations of VEGF in peritoneal fluid and its correlation with the stages of the disease were found.”

ClassificationTypes and staging systems5
By locationOvarian, peritoneal, deep infiltrating

The three most typical presentations: ovarian endometriosis (superficial lesions and "chocolate cyst" endometriomas, in 2–10% of reproductive-age women), peritoneal endometriosis (found in 15–50% of diagnosed women, in colors from white to red to black), and deep infiltrating nodules in the bowel or rectovaginal septum.

“The three most typical types of endometriosis are peritoneal endometriosis, ovarian cysts (chocolate cysts) and nodules of deeply infiltrating endometriosis in the gut or vaginal–rectal septum... Foci of endometriosis within the peritoneum are found in 15–50% of all women diagnosed with endometriosis... Ovarian endometriosis occurs in 2–10% of women of reproductive age and 50% of patients treated for infertility.”

1927 onwardSampson, then Martius and Kistner

Sampson’s original split was simply internal (within the uterine muscle) versus external. Martius later divided cases by anatomical zone — genitalis interna, genitalis externa, extragenitalis — while Kistner’s system organized lesions by specific structure: ovaries, uterine ligaments, bowel, or further afield in the pleura, skin or limbs.

“According to Sampson, we will divide it into: Internal endometriosis affecting the uterine muscle; External endometriosis occurring outside the uterine muscle.” The paper's Table 3 gives Martius's classification (endometriosis genitalis interna / externa / extragenitalis) alongside Kistner's classification (overlapping peritoneal endometriosis — ovaries, serous membrane, ligaments, tubes, intestine — and retroperitoneal endometriosis — inguinal region, neck/vagina/vulva/perineum, drainage pathways, pleura/lungs, skin/muscles/limbs).

1993Brosens' histological types

Ian Brosens proposed a tissue-level classification: mucosal type (found in ovarian endometriomas), peritoneal type (spanning early active lesions through to advanced black or white fibrotic ones), and glandular type, dominated by fibrous-muscular tissue and associated with deep infiltrating disease.

“Based on the histological classification according to Brosens (1993), we can distinguish types of endometriosis: Mucosal type (occurs in endometrial cysts of the ovary); Peritoneal type (exhibits multi-focus and morphological diversity) — early, active, glandular or follicular lesions, advanced, black, wrinkled changes, white fibrotic lesions; Glandular type (the main element is fibrous-muscular tissue and concerns deeply infiltrating endometriosis).”

Revised 1985The ASRM’s four stages

Based on laparoscopy or laparotomy findings, the American Society for Reproductive Medicine’s four-stage system — a revision of the original American Fertility Society scale — remains the most widely used in clinical practice, with stages I–II mild and III–IV advanced.

“The division developed by the American Fertility Association (AFS) is the most commonly used. The American Society of Reproductive Medicine distinguishes four stages of endometriosis, where stage I and II are fairly mild types, and stages III and IV are advanced disease. Currently, there is a division corrected by AFS in 1985... it is the most common system used in clinical practice.”

For deep diseaseThe ENZIAN scale

Built specifically for deep infiltrating endometriosis, ENZIAN scores both the presence and depth of invasion across anatomical compartments — A (vagina and rectovaginal septum), B (uterosacral ligaments to the pelvic wall), C (sigmoid colon and rectum) — plus separate codes for adenomyosis, and bladder, ureter, and bowel involvement.

“The ENZIAN scale in deeply infiltrating endometriosis is a descriptive scale, considering both the existence of the lesion and the depth of the invasion. In the ENZIAN classification, the location of foci was assigned to separate anatomical compartments — Compartment A: foci located in the vagina and the rectovaginal septum; Compartment B: foci located in the sacro-uterine ligaments up to the pelvic walls; Compartment C: foci located in the sigmoid colon and rectum.” Plus codes: “FA—adenomyosis, FB—urinary bladder endometriosis, FU—ureter endometriosis, FI—endometriosis of the bowel wall above the sigmoid colon, FO—infiltration of other anatomical structures.”

DiagnosticsFinding it4
First lineUltrasound

Standard ultrasonography is the basic diagnostic tool, useful for ovarian endometriomas and the congenital defects that predispose to retrograde flow. Where disease may involve the bladder or bowel, cystoscopy, colonorectoscopy or transrectal ultrasound are added.

“The basic examination in the diagnosis of endometriosis is an ultrasound examination. Ultrasound examination (ultrasonography, USG) is helpful in the diagnosis of endometrial cysts of the ovary and of congenital defects of the reproductive organs favoring the retrograde outflow of menstrual blood into the peritoneal cavity. In the case of endometriosis infiltrating the urinary bladder or the large intestine, it is justified to perform cystoscopy, colonorectoscopy and transrectal ultrasound examination.”

Gold standardLaparoscopy with histopathology

Direct visual and tissue confirmation via laparoscopic surgery remains the definitive diagnostic method, even as non-invasive imaging has improved. MRI is a useful adjunct; a two-handed pelvic exam with speculum can still catch disease in the vaginal vault or cervix that imaging misses.

“The gold standard in the diagnosis of endometriosis is laparoscopic surgery, with simultaneous confirmation in histopathological examination... It is also helpful to have a magnetic resonance imaging (MRI) examination, but the ultrasound examination is the basic tool in the diagnosis of this disease... examination with a speculum is an obligatory element of the gynaecological examination.”

For deep diseaseWater-contrast and transperineal ultrasound

Rectal water-contrast transvaginal sonography helps detect and stage bowel-area foci specifically. Transperineal ultrasound, meanwhile, has emerged as a reliable, non-invasive way to assess pelvic floor muscle tone and strength in women with deep infiltrating disease — functional information a scan for lesions alone won’t give you.

“In the case of deeply infiltrating endometriosis, the Rectal Water Contrast Transvaginal Sonography (RWC TVS) is also appropriate. The water contrast allows us to detect foci in the intestinal area and assess their progression... Transperineal ultrasound has been shown to be an important, reliable and non-invasive tool for assessing pelvic floor morphometry.”

The gapBetter tools, same delay

Despite this toolkit, the 8-to-10-year gap between symptom onset and diagnosis (see Symptoms) hasn’t closed — a reminder that diagnostic capability and diagnostic practice are two different problems.

This entry is our own connective observation, not a direct quotation — it draws together the paper's diagnostic-tools discussion with the 8–10 year diagnostic delay figure the same review states elsewhere (see “Symptoms”).

TreatmentPharmacological, surgical, physical4
Hormonal suppressionFive drug classes, one shared trade-off

Danazol, GnRH analogues, progestogens, combined oral contraceptives and the levonorgestrel IUD all work by suppressing estrogen — and all carry side effects tied to that suppression, from bone density loss to breakthrough bleeding. Aromatase inhibitors, the newest class, block estrogen production directly inside endometriosis lesions as well as the ovaries.

The paper's Table 4 lists: “non-steroidal anti-inflammatory drugs; hormonal drugs: progestogens, hormonal contraceptives, danazol, analogues and gonadoliberin (GnRH) – gonadoliberin agonists and antagonists; selective progesterone receptor modulators; aromatase inhibitors.” On the newest class: “Aromatase inhibitors—the latest group of drugs used in the treatment of endometriosis... Aromatase inhibitors interrupt oestrogen production in both endometriosis foci and ovaries, causing a significant reduction in oestrogen levels.”

FDA approvalElagolix

A GnRH antagonist approved on the strength of a roughly 1,700-patient trial, elagolix significantly reduced pelvic pain and pain during sex. The lower dose (150mg once daily) is cleared for 24 months of use; the higher dose (200mg twice daily) is capped at 6 months because of its effect on bone mineral density.

“The latest drug to be approved by the Food and Drug Administration (FDA) is elagolix, a drug for the treatment of moderate to severe pain associated with endometriosis. The results of a study in which about 1700 women with moderate or severe pain in endometriosis participated played a part in the above decision. Doses of this drug—150 mg once a day or 200 mg twice a day—significantly reduced the most common types of endometrial pain... For a dose of 150 mg, the duration of use of the drug is 24 months; for a dose of 200 mg duration is limited to 6 months, as the drug causes a decrease in bone mineral density.”

SurgicalLaparoscopy, with or without a robot

Laparoscopy is the recommended surgical approach regardless of disease stage, typically paired with pharmacological treatment before and after. Robot-assisted laparoscopy is a viable option for resecting deep infiltrating disease in the rectal-sigmoid region, though study results comparing it with conventional laparoscopy are mixed — some show longer relief, others show no difference at all.

“Laparoscopy is the recommended surgical technique for the treatment of endometriosis, regardless of its stage. The best therapeutic effects are achieved as a result of the combination of surgical treatment with pharmacological treatment... Laparoscopy with the assistance of a robot is a viable method of resection of deeply infiltrating endometriosis, especially in the rectal-sigmoid region... Laparoscopically assisted robotics are associated with longer duration of relief than laparoscopic surgery, but the results are controversial.”

A newer additionPelvic floor physiotherapy

Manual and osteopathic techniques targeting adhesion-related pelvic floor dysfunction can meaningfully improve quality of life alongside standard treatment. The evidence for exercise itself is thinner — plausible anti-inflammatory benefits, but no controlled trials yet confirm it helps, and some patients find the discomfort of endometriosis makes exercise harder rather than protective.

“Physiotherapy in endometriosis focuses on non-invasive and conservative treatment of pelvic floor disorders in women. It deals with the restoration of the efficiency and function of tissues and organs in the pelvic area, supports the process of surgical treatment, relieves pain, thus improving the quality of life... Analysis of the available literature data shows that there are no controlled and randomised trials determining whether and to what extent exercise can be beneficial for women with endometriosis.”

Biomarkers & geneticsThe active research frontier5
Still missingNo validated blood test

Despite years of searching, no biomarker is sensitive and specific enough to diagnose endometriosis from blood, plasma or urine alone. Ca-125 and Ca-19-9 have found partial clinical use, but Ca-125's sensitivity is limited to advanced disease and it’s often elevated in unrelated gynecological conditions too.

“So far, no specific marker for endometriosis has been identified... The only markers that have found partial clinical use in the diagnosis of endometriosis are the glycoproteins Ca-125 and Ca-19-9. The sensitivity of Ca-125 is characteristic of the advanced form of the disease, but its specificity is low because it is often elevated in other gynaecological diseases.”

Closest candidateIL-6, and a new entrant, YKL-40

Among cytokines and growth factors tested, IL-6 has the most reproducible results — 63% sensitivity, 69% specificity. YKL-40, an inflammation marker secreted by activated macrophages, is elevated in endometriosis patients versus healthy controls and is under active study as a monitoring tool.

“The most reproducible results were obtained for IL-6. IL-6 is the most characteristic of endometriosis. Its sensitivity is 63% and its specificity is 69%... YKL-40, a new biomarker of inflammation, is secreted by activated macrophages and neutrophils in various inflamed tissues... It was shown that the level of YKL-40 was significantly higher in patients with endometriosis compared with healthy women.”

EmergingMicroRNAs as a diagnostic frontier

Circulating microRNAs — short RNA fragments stable enough to detect in serum — are a live area of research. Members of the let-7 family dominate in endometrial cells; specific signatures like miR-199b-3p, miR-224-5p and let-7d-3p in plasma are being explored as diagnostic candidates, though none are clinically validated yet.

“MicroRNAs are small ribonucleic acid molecules about 22 nucleotides long that regulate gene expression by influencing the translation process... MicroRNAs from the let family are among the dominant in endometrial cells... Recent studies showed that the levels of miRNAs 199b-3p, 224-5p, and Let-7d-3p in plasma are potential diagnostic biomarkers for endometriosis patients.”

2010–2012The genome-wide association era begins

The first genome-wide association studies (GWAS) on endometriosis, published in 2010–2011 across Japanese and European cohorts, implicated the WNT4 and CDKN2BAS genes. In 2012, an international team ran the largest study to date — 5,586 women with endometriosis against 9,331 without — and confirmed a locus on chromosome 7 involved in uterine development, alongside the WNT4 region tied to hormone metabolism.

“The first GWAS study on endometriosis was published between 2010 and 2011—two papers on the Japanese population and one study of European women... In 2012, an international team of scientists conducted the largest genome-wide association study to date, the first among European women comparing DNA from 5586 women with endometriosis and 9331 people free of the disease. The team identified two regions of the genome associated with an increased risk of endometriosis. The first is located on chromosome 7... The second variant is located near the WNT4 gene, which is involved in hormone metabolism.”

2019 and afterMore loci, and somatic mutations in lesions themselves

Albertsen and colleagues' 2019 GWAS of 2,019 surgically confirmed cases added further risk loci near WNT4 and elsewhere. Separately, next-generation sequencing of deep infiltrating lesions has turned up somatic mutations — changes absent from the germline, found only in the lesion tissue itself — in genes including ARID1A, KRAS, PIK3CA and PPP2R1A, some of them known cancer-initiating mutations, though their role in endometriosis is still being worked out.

“Albertsen et al. conducted a GWAS study in the European population of 2019 surgically confirmed cases of endometriosis and 14,471 controls. Three of the single nucleotide polymorphisms (SNPs) associated with the disease have been identified...” Separately: “The occurrence of de novo mutations in both the endometrial cyst epithelial and peritoneal foci as well as in DIE foci is described. The most frequently noted genes are: ARID1A, KRAS, PIK3CA and PPP2R1A.”

Part One source

Brosens I, Benagiano G. Endometriosis, a modern syndrome. Indian Journal of Medical Research, June 2011;133(6):581–593. Read the full paper, open access under CC BY-NC-SA 3.0. Undated observations from the review are not shown above — among them the 1980s recognition that peritoneal lesions appear in red, black, and white forms, and the late-1990s work on endometrial receptivity and aberrant integrin expression.

Part Two source

Smolarz B, Szyłło K, Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). International Journal of Molecular Sciences, 2021;22(19):10554. Read the full paper, open access under CC BY 4.0. Citation-dense passages — cytokine tables, individual polymorphism studies — are summarized rather than reproduced in full; consult the source paper for the complete reference list.

About this page

The text was edited by The 72 Fund for readability. The small icon () next to each entry opens the exact passage it's based on, so the underlying research is never more than a click away. The two reviews are ten years apart, written by different teams, and organized on different principles — one chronological, one topical — so they’re presented separately rather than merged into a single narrative. For the complete, unabridged research, please see the original papers linked above.